CPHI Milan

FUJIFILM Diosynth Biotechnologies is thrilled to sponsor the Future of Pharma and Ingredients Theatre in Hall 22 in addition to exhibit at CPHI, October 8-10, 2024 in Milan, Italy. Connect with our team via the event planner app or stop by booth 5B129 to learn more about our capabilities and how we can become Partners for Life.

Join our Presentation in Hall 22 Future of Pharma and Ingredients Theatre
Wednesday – October 9th @ 13:45

Dr. AJ Troiano, Global Director of Biosafety and Toxicology at FUJIFILM Diosynth Biotechnologies is presenting on Patient Safety in CDMO Operations: Leveraging Quality and Toxicology Synergies to Accelerate Manufacturing Pipelines

Even though it should be considered part of our everyday business, is it standard for multimodal CDMOs to truly operate with a holistic quality mindset, prioritizing the health and safety of both workers and patients?   At FUJIFILM Diosynth Biotechnologies, quality and safety are two sides of the same coin, with our customers’ patients sitting at the interface of the two.  Manufacturing biologically-derived drug substances require pushing the envelope on innovation while maintaining unprecedented quality delivery and meeting regulatory requirements. This mandates a synergistic relationship among safety, quality, and customer stakeholders, specifically in our new product introduction, risk assessment, and risk mitigation processes.

This presentation will highlight the unique infrastructure FUJIFILM Diosynth Biotechnologies has built around safety operations and quality, with a focus on our new product introduction and patient risk assessments. The beginning of every drug substance’s manufacturing journey begins with a carefully crafted toxicology assessment and mitigation plan that is predicated on a strong customer mindset, optimizing operational efficiency and accelerating pragmatic risk management solutions. Whether it is an early phase gene therapy or commercial scale protein therapeutic, we partner with customers at every stage of their manufacturing journey to provide appropriate risk management solutions and protect the customers’ patients we ultimately serve

Click here for the conference agenda